Advantages: The IV port has the following advantages over the original central venous access for intravenous therapy: (1) Significantly reduced blood regurgitation, air embolism and thrombosis. (2) Patented triple-valve venous catheter eliminates the need for heparin sealant (3) Subcutaneous implantation reduces patient infection rates by 56% (4) Daily maintenance is reduced from weekly to monthly, simplifying care and reducing maintenance costs. (5) For strong local chemotherapy drug delivery, the channel has high convenience and practicality. (6) It is particularly suitable for patients who are fearful of venipuncture and for patients who cannot manage unconscious extraction of exposed catheters, such as children. (7) Patients’ quality of life is improved, no dressing is required, and patient privacy is protected. Prospects: The establishment of an infusion port access, a completely buried subcutaneous infusion device that does not interfere with patients’ bathing, swimming, etc., improves patients’ quality of life; the frequency of monthly maintenance reduces the frequency of patients’ trips to and from the hospital. It improves the efficiency of medical services while not affecting patients’ physical activities and protecting their privacy. This technology has been developed and matured in Beijing, Shanghai and Guangzhou, and is gradually replacing PICC as the first choice for medium and long-term infusion patients. Currently 80% of infusion ports are used for cancer treatment, while up to 60% are used for breast cancer treatment, and other application groups are lung cancer, lymphoma, leukemia, ovarian cancer, and colorectal cancer in that order. After a long preparation, our department has successfully carried out infusion port implantation. And we have a formally trained specialist nursing team for perioperative care!